Although crystallins are major structural proteins in the lens, a-crystallins perform non-lens functions, and aB-crystallin has been shown to act as an anti-apoptotic mediator in various cells. The present study was undertaken to examine whether aB-crystallin expressed in human malignant glioma cells exerts anti-apoptotic acitivity. In addition, we sought to elucidate the mechanism underlying any observed anti-apoptotic function of aB-crystallin in these cells. Three glioma cell lines, U373MG, U118MG, and T98G, were used. We observed that only the U373MG cell line expresses aBcrystallin, whereas the other 2 glioma cell lines, U118MG and T98G, demonstrated no endogenous expression of aB-crystallin. We next observed that the silencing of aB-crystallin sensitized U373MG cells to suberoylanilide hydroxamic acid (SAHA) -induced apoptosis and that aB-crystallin associates with caspase-3 and XIAP. Because XIAP is the most potent suppressor of mammalian apoptosis through the direct binding with caspases, we assessed whether XIAP also plays an anti-apoptotic role in SAHA-induced apoptosis in aB-crystallin-expressing U373MG cells. Of note, the silencing of XIAP did not alter the amount of cell death induced by SAHA, indicating that XIAP does not exert an anti-apoptotic activity in U373MG cells. We then determined whether the ectopic expression of aB-crystallin in glioma cells caused a loss of the anti-apoptotic activity of XIAP. Accordingly, we established 2 aB-crystallin over-expressing glioma cell lines, U118MG and T98G, and found that the silencing of XIAP did not sensitize these cells to SAHA-induced apoptosis. These findings suggest that aB-crystallin expressed in glioma cells overrides the anti-apoptotic activity exerted by XIAP.
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a -Crystallin is a major protein in the eye lens of vertebrates and is found as large aggregates of 2 closely related subunits, aA and aB. 1 Both aA-crystallin and aB-crystallin are also distributed outside the vertebral eye lens. 2, 3 Thus, entirely different non-lens roles for a-crystallins have been suggested.
Previous studies have shown that aB-crystallin is a member of the conserved small heat shock family of proteins and acts as a morecular chaperone induced by various stress stimuli, coferring cytoprotection by suppressing aggregation of denatured protein. 4 aBcrystallin is also responsible for the control of the cell cycle and neoangiogenesis in the process of metastases and invasion. 5 Accumulating evidence indicates that aB-crystallin negatively regulates apoptosis.
Apoptosis is a cellular process that plays crucial roles in multiple physiological and pathological events and is regulated by positive and negative regulators in series. 6 Apoptosis is distinguished by nuclear condensation and DNA fragmentation 7 and is executed by an activity of a family of cysteine proteases known as caspases. 8 Caspases, which are divided into initiators (caspases-2, -8, -9, and -10) and effectors (caspase-3, -6, and -7) based on their relative position in the signaling cascade, 9 are expressed in essentially all metazoan cells as catalytically inactive zymogens known as procaspases. 10 Of importance, caspase-3 plays a role in executing apoptosis. 11 To date, many proteins have been identified as substrates of caspase-3.
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To date, several cancer cells, such as gliomas, breast carcinomas, and renal cell carcinomas, have been demonstrated to express aB-crystallin, 13 -17 and the expression of aB-crystallin correlates with poor clinical outcomes in various cancers. 15, 18 The expression of aB-crystallin protects cancer cells from apoptosis and contributes to the aggressive behavior of diverse carcinomas, 15, 19 and chemotherapy has been shown to enhance the expression of aB-crystallin in cancer cells.
Irrespective of accumulating evidence supporting that aB-crystallin provides anti-apoptotic protection against various apoptotic effectors, little progress has been made in understanding the molecular mechanisms underlying their action. aB-crystallin inhibits autocatalytic maturation of caspase-3 preventing. 20 aB-crystallin prevents apoptosis induced by staurosporine by interacting with Bax and Bcl-2 and inhibiting their translocation from the cytosol to the mitochondria. 21 More recently, Sreekumar et al. have shown that aB-crystallin protects stressed retinal pigment epithelial cells from apoptosis by inhibiting caspase-3 and PARP (poly [ADP-ribose] polymerase) activation. 22 aB-crystallin was observed to prevent apoptosis induced by hydrogen peroxide treatment by interacting with p53 in the cytoplasm and preventing its translocation to mitochondria. 23 In addition, alphaB-crystallin was known as a novel p53-target gene and required for p53-dependent apoptosis. 24 aB-crystallin overexpression decreases cell apoptosis by preventing RAS activation and inhibiting the RAF/ MEK/ERK pathway. 25 Glioblastoma multiforme (GBM) is the most common type of brain tumor and is known as an aggressive, highly invasive, and destructive tumor among human cancers. 26, 27 Moreover, GBM responds poorly to conventional therapy. 28 Previous studies showed that the level of aB-crystallin expression is elevated in glioblastoma. 29 aB-crystallin is elevated in highly migratory glioblasma cells, where it plays a functional role in apoptosis resistance. 30 aB-crystallin is known to enable Bcl2-Like 12 to block the activation of capase-3 and -7, thereby contributing to GBM pathogenesis and its hallmark biological properties. 31 A histone deacetylase inhibitor (HDACi), suberoylanilide hydroxamic acid (SAHA), was demonstrated to be effective against various glioma cell lines at a range of 1-10 mM. 32 Histone acetylation is maintained by histone acetyl transferases (HATs) and histone deacetylases (HDACs), and changes in the histone acetylation patterns are correlated with gene transcription and cause many diseases. 33 HDACs selectively induce apoptosis in many tumor cell types. 34 However, nontumorigenic cells clearly showed resistance to the cell death induced by HDAC inhibitors. 33 The present study was undertaken to examine whether aB-crystallin expressed in human malignant glioma cells exerts anti-apoptotic acitivity. We observed that aB-crystallin endogenously and ectopically expressed in U373MG human glioma cells inhibits the cytotoxicity by SAHA and various anticancer agents. Furthermore, we observed that aB-crystallin expressed in human glioma cells overrides the anti-apoptotic activity exerted by XIAP.
Materials and Methods

Materials
The following reagents were obtained commercially: rabbit polyclonal anti-human caspase-3, caspase-9, caspase-12, HSP60, survivin, GAPDH and mouse monoclonal anti-human caspase-7, HSP70, HSP90 antibodies, and temozolomide (TMZ) from Santa Cruz Biotechnology; mouse monoclonal anti-human poly(ADP-ribose) polymerase (PARP) antibody from Oncogene; rabbit polyclonal anti-human caspase-6 and caspase-8 antibodies from Cell Signaling; mouse monoclonal anti-cytochrome c antibodies from BD Transduction Laboratories; FITC-conjugated goat antirabbit, horse anti-mouse IgG antibodies from Vector; HRP-conjugated donkey anti-rabbit and sheep antimouse IgGs from Amersham Pharmacia Biotech; mouse monoclonal anti-human b-actin antibodies, Hoechst 33342, dimethyl sulfoxide (DMSO), RNase A, proteinase K, propidium iodide (PI), valproic acid (VPA), resveratrol, etoposide, doxorubicin, blasticidin and cisplatin (CisPt) from Sigma-Aldrich; 3,3 ′ -dihexyloxacarbocyanine iodide (DiOC 6 ) and mitotrackers from Molecular Probes; SAHA and MS-275 from Alexis Biochemicals; and SuperSignal West Pico enhanced chemiluminescence Western blotting detection reagent from Pierce.
Cell Culture
T98G, U118MG, U373MG, and ARPE19 cells were obtained from the American Type Culture Collection (ATCC). The culture medium used throughout these experiments was DMEM/F-12 (ARPE19) and RPMI-1640 media (GibcoBRL) with 10% fetal bovine serum (FBS; GibcoBRL), 20 mM HEPES and 100 mg/mL penicillin in 5% CO 2 at 378C.
aB-Crystallin Plasmid Construct and Establishment of 3x Flag-aB-Crystallin Over-Expressing Glioma Cell Lines
Human full-length aB-crystallin cDNA (CRYAB; accession number: NM_001885) was purchased from 21 Century Human Gene Bank and subcloned into pcDNA6-3xFlag. pcDNA6-3xFlag was constructed by inserting the 3xFlag tag sequence between NheI and EcoRI sites of pcDNA6 (Invitrogen). The primers used were as follows:
and CRYABRev (5 ′ -TTTCT AGACTATTTCTTGGGGGCTGCGGTGACAGC -3 ′ ). The EcoRI and XbaI sites are underlined respectively. The PCR-amplified aB-crystallin gene was cloned between the EcoRI and XbaI sites, which generated in-frame fusion with 3xFlag. All constructs were verified by sequencing. U118MG and T98G cells were transfected using lipofectamine 2000 (Invitrogen) reagent according to the manufacturer's instructions. The transfected cells were incubated for 2 days, and stable cell lines were then selected with changes of fresh medium containing blasticidin (10 mg/mL) for 4 weeks. Singlecell clones were isolated by limiting dilutions and subsequently analyzed for an increase of aB-crystallin protein expression relative to identically cloned empty vector controls.
Transient Transfection of XIAP
Human full-length XIAP cDNA (BIRC4; accession number: BC032729) was purchased from OpenBioSystem (OpenBioSystem). Human XIAP cDNA was inserted between NheI and EcoRI sites of MCS A in the pIRES plasmid (Clontech; catalog # 631605) containing 2 multiple cloning sites (MCS) A and B that allows expression of 2 genes of interest. Transient transfection of XIAP was performed using the lipofectamine 2000 (Invitrozen).
Cell Viability Assay
Cell viability was determined by the Vi-Cell cell counter (Beckman Coulter), which performs an automated trypan blue exclusion assay.
Nuclear Morphology Analysis of Apoptosis
Cell suspensions were cytospun onto clean fat-free glass slides using a cytocentrifuge. Centrifuged samples were fixed for 10 min in 4% paraformaldehyde and stained in 4 mg/mL Hoechst 33 342 for 30 min at 48C. Cells were observed and photographed under an epifluorescence microscope by an observer who was blinded to the experimental group. To quantify cells showing nuclear fragmentation, the total cell number (100 cells from each experiment) was counted using differential interference contrast (DIC) optics.
Quantification of DNA Hypoploidy and Cell Cycle Phase Analysis by Flow Cytometry
Ice-cold 95% ethanol with 0.5% Tween 20 was added to the cell suspension to a final concentration of 70% ethanol. Fixed cells were pelleted and washed in 1% BSA-PBS solution. Cells were re-suspended in 1 mL PBS containing 11 Kunitz U/mL RNase, incubated at 48C for 30 min, washed once with BSA-PBS, and resuspended in PI solution (50 mg/mL). After cells had been incubated at 48C for 30 min in the dark and washed with PBS, DNA content was measured on an Epics XL (Beckman Coulter), and data were analyzed using Multicycle software, which allowed a simultaneous estimation of cell cycle parameters and apoptosis.
Western Blot Analysis
Equal amounts of proteins were run on 7.5% -15% sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The proteins were transferred to a nitrocellulose membrane (Amersham Pharmacia Biotech) and reacted with each antibody. Immunostaining with antibodies was performed using SuperSignal WestPico enhanced chemiluminescence substrate and detected with LAS-3000 Plus (Fuji Photo Film).
Immunocytochemistry and Confocal Microscopy
Cells grown in 2-well chamber slides were treated as indicated, fixed with 4% paraformaldehyde for 10 min, permeabilized with 0.2% Triton X-100 for 15 min, and then blocked with 2% bovine serum albumin for 1 h at room temperature (RT). Cells were probed with mouse monoclonal anti-cytochrome c (1:75) overnight at 48C, followed by staining with goat anti-mouse Alexa Fluor 488 antibody (1:100, Molecular Probes for 1 h at RT). After washing, cells were mounted with SlowFade Light antifade reagent (Molecular Probes) and analyzed by confocal microscopy. To visualize the mitochondria in living cells, 20 nM mitotracker CMXRos was added and incubated for 20 min. Fluorescent images were observed and analyzed under Zeiss LSM 700 laser-scanning confocal microscope.
siRNA
For XIAP depletion, pre-designed siRNA constructs were purchased from Dharmacon (ON-TARGET plus siRNA J-004098-14-0050). aB-crystallin target sequence (5 ′ -AAU UGA CCA GUU CUU CGG AGA -3 ′ ) was synthesized by Dharmacon Research through the ready-to-use option using 21-nucleotide RNA with 3 ′ -dTdT overhangs. As a negative control, the same nucleotides were scrambled to form a non-targeting combination. siRNAs were transfected using siPORT Amine (Ambion) in Opti-MEM (GibcoBRL). Cells grown to a confluency of 40% -50% in 6-well plates were transfected with 200 nM final siRNA concentration per well.
Twenty-four hours after transfection, apoptotic stimuli were applicated.
Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR)
Total RNA was extracted from the cultured cells using the Qiagen RNeasy Mini Kit (Quiagen). Total RNA (2 mg) was reverse transcribed using oligo-dT primers and M-MLV reverse transcriptase. RT-PCR products containing aB-crystallin and b-actin were amplified using gene a specific primer (aB-crystallin: F-TCC CCA GAG GAA CTC AAA GTT AAG, R-GGC GCT CTT CAT GTT TCC A, b-actin: F-TGA CGG GGT CAC CCA CAC TGT GCC CAT, R-CTA GAA GCA TTT GCG GTG GAC GAT GGA GGG). PCR (40 mL) was performed in reaction mixes containing 3 mL cDNA, 10 mM primers, 2.5 mg/mL Go Tag Flexi DNA polymerase (Promega), 50 mM KCl, 10 mM Tris-HCl (pH, 9.0), 3.0 mM MgCl 2, and 0.2 mM dNTPs. PCR was performed in a 9700 Thermocycler (PerkinElmer), and the general thermocycling conditions were as follows: 1 cycle of 2 min of initial denaturation at 958C, followed by 30 cycles of 30 s at 958C, annealing for 40 s at 558C and reaction for 100 s at 728C, followed by a final 5 min extension at 728C. PCR products were separated by gel electrophoresis using 2% SeaKem LE agarose in 1X TAE buffer.
Assay of Mitochondrial Membrane Potential (MMP)
3,3
′ Dihexyloxa carbocyanine iodide (DIOC 6 ) was added directly to the cell culture medium (1 mM final concentration). After 30 min incubation, the cells were pelleted and resuspended with PBS. The cells were submitted to flow cytometry on the Epics WL (Beckman Coulter) to measure the MMP. Data were acquired and analyzed using EXPO32 ADCXL 4 color software. The analyzer threshold was adjusted on the forward scatter channel to exclude noise and most of the subcellular debris.
Co-immunoprecipitation (Co-IP)
Cell extracts that were incubated with antibodies were precipitated with protein A-Sepharose beads. Immunoprecipitated proteins were separated on SDS-PAGE, and Western blot analysis was performed as described. Each Co-IP experiment was confirmed via reciprocal IP.
Statistical Analysis
Four independent experiments were conducted in vitro. The results are expressed as the means + standard deviations from 4 experiments, each performed in triplicate. Statistical significance of differences was determined using the paired Kruskal-Wallis nonparametric test. A P value ,.05 was considered to be statistically significant.
Results
aB-Crystallin Is Expressed in Human U373MG Glioma Cells
We first screened the expression of aB-crystallin in 3 glioblastoma cell lines: U373MG, U118MG, and T98G. An RT-PCR assay showed the expression of the aB-crystallin gene in U373MG cells but not in U118MG and T98G cells (Fig. 1A) . A Western blot assay further confirmed the expression of the aB-crystallin protein in U373MG cells but not in U118MG and T98G cells (Fig. 1A) . To examine the prevalence of the expression of aB-crystallin, we evaluated gene expression profile data from The Cancer Genome Atlas Network. 35 Our test on CRYAB expression between normal tissues and subtypes (proneural, neural, classical, and mesenchymal) from the cohort of GBM showed that the expression of CRYAB was significantly up-modulated in the neural subtype (P , .001).
Human Glioma U373MG Cells Undergo Apoptosis After Treatment with SAHA.
To explore the anti-apoptotic role of aB-crystallin in glioma, aB-crystallin-expressing U373MG cells were treated with a histone deacetylase inhibitor, SAHA. SAHA treatment significantly decreased the viability of U373MG cells in a dose-dependent manner (Fig. 1B) . Because the viability of the U373MG cells treated with 10 mM for 48 h was approximately 50%, this concentration was used solely in our further analyses. At 10 mM, SAHA significantly reduced the viability of U373MG cells in a time-dependent manner (Fig. 1C) . Further assays were then undertaken to determine whether U373MG cells treated with SAHA undergo apoptosis. Western blot assays demonstrated the production of caspase-3, -6, -7, -8, -9, and 12 cleavage products in cells treated with SAHA. Western blotting assay also showed the degradation of PARP and the production of its cleavage product (Fig. 1D) . Confocal microscopy demonstrated that SAHA induced the release of cytochrome c from the mitochondria in U373MG cells (Fig. 1E) , and Hoechst staining showed that the cells treated with SAHA had fragmented atypical nuclei (Fig. 1F) . By flow cytometry, we found that SAHA increased the subdiploid apoptotic population in the U373MG cells (Fig. 1F) . These data suggested that the cell death induced by SAHA in U373MG cells is apoptotic. Although SAHA treatment decreased the level of the aB-crystallin protein, the levels of other HSPs (60, 70, and 90) were sustained. Anti-apoptotic factors, such as survivin and XIAP, were substantially downregulated by the SAHA treatment (Fig. 1G) .
siRNA Against aB-crystallin Sensitizes U373MG Cells to SAHA-Induced Cell Death
To examine whether the silencing of aB-crystallin sensitized the U373MG cells to SAHA-induced apoptosis, the cells were treated with SAHA at 2 mM, a dose that alone did not reduce the viability of the U373MG cells. Of note, the silencing of aB-crystallin by siRNA significantly sensitized the U373MG cells to SAHA and led to cell death ( Fig. 2A) . Flow cytometry showed that the silencing of aB-crystallin augmented the accumulation of subdiploid apoptotic cells (Fig. 2B) , and confocal microscopy showed that the aB-crystallin siRNA markedly depleted aB-crystallin in the U373MG cells treated with SAHA, which showed nuclear condensation or fragmentation (Fig. 2C) . Hoechst staining showed that the silencing of aB-crystallin enhanced the nuclear fragmentation and condensation (Fig. 2D) . A Western blotting assay showed that the silencing of Fig. 1 for other definitions. Si, small interfering RNA directed against aB-crystallin; sc, scramble control. Lee et al.: aB-crystallin overrides the activity of XIAP aB-crystallin enhanced the production of the cleavage products of caspase-3, -7, -8, and -12. Although the silencing of aB-crystallin augmented the degradation of XIAP, it did not substantially downregulate Hsp60 or Hsp70 (Fig. 2E) . Flow cytometry also showed that the silencing of aB-crystallin enhanced the reduction of MMP (Fig. 2F) . These data indicate that endogenously expressed aB-crystallin exerts an anti-apoptotic role in U373MG cells.
aB-Crystallin Inhibits the Cytotoxicity by SAHA in Glioma Cells
A viability assay using the 3 glioma cell lines treated with different concentrations of SAHA showed that the U373MG cells endogenously expressing aB-crystallin are more resistant to SAHA-induced cytotoxicity, as by SAHA compared with the other 2 glioma cell lines, U118MG and T98G, which did not endogenously express aB-crystallin (Fig. 3A) . We next examined whether the ectopic expression of aB-crystallin in the U118MG and T98G cells protects them from the cytotoxicity by SAHA. aB-crystallin was transiently transfected into the U118MG and T98G cells, and the cells were then treated with 2 mM SAHA. Of note, 2 mM SAHA substantially induces cell death in the control cells containing empty vector, U118MG/vec and T98G/vec, but not in the typical U373MG cells. Of importance, the transient over-expression of aB-crystallin prevented the reduction of viability induced by SAHA in both of the U118MG/vec and T98G/vec cells (Fig. 3B -D) . We next established aB-crystallin-overexpressing U118MG and T98G cells, and these cells were treated various doses of SAHA. Of note, the aB-crystallin -over-expressing U118MG and T98G cells were markedly resistant to SAHA when compared with each control cell containing the empty vector ( Fig. 3E) . These results indicate that aB-crystallin inhibits the cytotoxicity induced by SAHA in glioma cells.
aB-Crystallin Associates with XIAP and Caspase Subtypes
Because previous reports showed that aB-crystallin regulates apoptosis through interactions with caspase-3, we next examined whether caspase subtypes associates with aB-crystallin in U373MG cells. We screened capases-3, -6, -7, -8, -9, and -12 in the control U373MG cells with use of a co-immunoprecipitation assay and found that aB-crystallin interacted with all of the caspase subtypes tested (Fig. 4A) . Because XIAP is known to associate with these caspase subtypes, we examined whether XIAP interacts with these caspase subtypes in U373MG cells. As predicted, XIAP interacted with aB-crystallin and these caspase subtypes in U373MG cells (Fig. 4B and C) . Furthermore, the SAHA treatment dissociated these caspase subtypes from aB-crystallin and XIAP and dissociated XIAP from aB-crystallin (Fig. 4A-C) . aB-crystallin also physically interacted with all caspase subtypes and XIAP in stable, aB-crystallin -over-expressing glioma cells, U118MG/ aBC and T98G/aBC cells (Fig. 4D , Western blot data on caspase-6, -7, -8, -9, and -12 are not shown).
aB-Crystallin Endogenously Expressed in U373MG Cells Overrides the Anti-Apoptotic Activity of XIAP
Previous studies reported that aB-crystallin exerts antiapoptotic activity by binding and sequestering cell death -related factors. Because we observed that aB-crystallin is associated with XIAP in U373MG cells in which endogenously expressed aB-crystallin plays a pivotal anti-apoptotic role, we asked whether XIAP also functions as an anti-apoptotic factor in these cells. Because the silencing of aB-crystallin sensitized the U373MG cells to 2 mM SAHA and led to apoptosis (Fig. 2) , we tested whether the silencing of XIAP sensitizes the U373MG cells to 2 mM SAHA and led to apoptosis. Of note, the silencing of XIAP did not significantly alter the amount of apoptosis induced by SAHA in the U373MG cells, as determined by various assays that evaluate apoptosis (Fig. 5A-D) . Western blotting assay and confocal microscopy confirmed that the caspase subtypes are not activated in the U373MG cells treated with 2 mM SAHA, even though the XIAP protein was efficiently depleted by siRNA (Fig. 5E and Supplementary Fig. S1 ). Although the aB-crystallin siRNA substantially downregulated the XIAP protein expression and abolished the interaction between XIAP and caspase-3, the XIAP siRNA altered neither the expression level of the aB-crystallin protein nor the interaction between aB-crystallin and caspase-3 ( Fig. 5F and G) . We next examined functional hierarchy between aB-crystallin and XIAP. Of importance, transient overexpression of XIAP reversed neither the downregulation of aB-crystallin by SAHA treatment nor the cell death induced by aB-crystallin knockdown in presence of SAHA (Fig. 6A and B) . These data indicate that, unlike aB-crystallin, XIAP does not function as a major anti-apoptotic factor in U373MG cells. Ectopic Expression of aB-Crystallin in Human Glioma U118MG and T98G Cells Overrides the Anti-Apoptotic Activity of XIAP We next examined whether XIAP sustains its antiapoptotic activity in the human glioma cells that are ectopically expressing aB-crystallin. We treated the cells with 2 mM SAHA, which slightly induced apoptosis in U118MG/vec and T98G/vec cells. We found that viability was slightly reduced and that the cleavage product of caspase-3 was produced in both the U118MG/vec and the T98G/vec cells. Furthermore, the XIAP siRNA augmented the level of the cleavage product of caspase-3 and the amount of cell death, indicating that XIAP exerts its anti-apoptotic activity ( Fig. 7A and B) . Of importance, the XIAP siRNA did not augment the level of the caspase-3 cleavage product or the amount of cell death in aB-crystallinover-expressing T98G and U118MG cells (Fig. 7C and  D) . These data suggest that the ectopic expression of aB-crystallin in human glioma U118MG and T98G cells overrides the anti-apoptotic role of XIAP.
Endogenous or Ectopic Expression of aB-Crystallin Decreases the Sensitivity of Glioma Cells to Various Anti-Cancer Drugs
We examined whether aB-crystallin confers chemoresistance to various anti-cancer drugs in glioma cells. The 3 glioma cell lines were treated with 7 anti-cancer drugs, and a viability assay was performed. Our data show that the U373MG cells are more chemoresistant than are the other 2 cell lines (Fig. 8A) . Of importance, we found that silencing of aB-crystallin but not XIAP sensitized U373MG cells to anti-cancer drug-induced cell death (Fig. 8B) . We further examined the effect of the ectopic expression of aB-crystallin in the U118MG and T98G cells and found that the aB-crystallin -overexpressing U118MG and T98G cells were more chemoresistant than were the control cells containing the empty vector ( Fig. 8C and D) .
Discussion
Numerous HDACis have been characterized, and SAHA is an HDACis that is known as a therapeutic agent under various cell-proliferating conditions. 33 In preclinical studies, SAHA, an inhibitor of several members of the HDAC protein family, 34 has also been observed to have anti-glioma activity. SAHA causes glioma cells to accumulate in the G2-M phase of the cell cycle, decreases the levels of cyclin-dependent kinase, and inhibits glioma cell growth in orthotopic models. 36 The present study has also demonstrated that SAHA shows antiglioma activity by causing apoptotic cell death in human glioma U373MG cells.
aB-crystallin is expressed in some glioma cells, such as U138MG, LN-319, and U373MG cells. 37 Furthermore, previous studies reported that aB-crystallin is mainly expressed in experimental xenograft models and in human gliomas in situ. 30 Although little is known about its functional role in tumor progression, 30 aB-crystallin has been shown to be expressed in high-grade gliomas. 38 The present work showed that aB-crystallin is expressed in U373MG glioma cells but not in T98G and U118MG glioma cells and that the expression of CRYAB was significantly up-modulated in the neural subtype.
On the basis of previous studies, the molecular role of aB-crystallin in glioma cells can be predicted. aBcrystallin is a member of the small heat shock protein family, which also includes Hsp27, whose members have a high degree of sequence homology. 39 Thus, aB-crystallin could exert its activity as molecular chaperone in glioma cells. Hsps function as stress-induced molecular chaperones to inhibit the aggregation of denatured proteins, thereby promoting cell survival. 40 Although both aB-crystallin and Hsp27 prevent cells from stress-induced apoptosis at various signaling steps, the exact mechanism or regulating targets seem to be different. 41 -43 Other studies showed that the ectopic expression of aB-crystallin in diverse cell types protected cells against diverse apoptotic stimuli, including TNF-a, TNF-related apoptosis-inducing ligand (TRAIL), etoposide, growth factor deprivation, and oxidative stress. In addition, the silencing of aB-crystallin expression by RNA interference (RNAi) sensitizes cells to apoptosis. 44 In the study presented here, we observed that the silencing of aB-crystallin by siRNA sensitized the U373MG cells to sublethal doses of SAHA, indicating that aB-crystallin caused the inhibition of toxicity by SAHA in the U373MG cells. A previous study demonstrated that aB-crystallin binds to both procaspase-3 and the partially processed procaspase-3 intermediate, preventing apoptosis. 45 The present study suggests that an entirely different mechanism underlies the antiapoptotic activity exerted by aB-crystallin. According to the data obtained in the present study, aB-crystallin expressed endogenously or ectopically in human glioma cells overrides the anti-apoptotic role of XIAP.
Mammals have developed regulatory proteins, members of the IAP (inhibitor of apoptosis) family, which target a subset of the caspases. 46 The IAP family, including XIAP, cIAP1, and cIAP2, are capable of directly inhibiting the effector, caspase-3. 47 Among the IAP family members, the X chromosome-linked inhibitor of apoptosis protein (XIAP) is considered as the most potent suppressor of cell death. 48 Previous studies showed that the knocking down of XIAP with siRNA or antisense oligonucleotides generally restores chemosensitivity to a variety of malignant cell lines. 49, 50 Furthermore, some reports demonstrated that the downregulation of XIAP induces apoptotic death in human glioblastoma cells. 51 However, XIAP functions as an antiapoptotic factor in neither U373MG cells, which are endogenously expressing aB-crystallin, nor in U118MG and T98G cells ectopically over-expressing aB-crystallin. Accordingly, aB-crystallin expressed endogenously or ectopically in human glioma cells seems to override the antiapoptotic activity of XIAP. This is supported by the data indicating that aB-crystallin confers glioma cells the chemoresistance to various anti-cancer drugs.
The combined treatment to reduce tumor formation in various cancer cells may represent an effective cancer treatment for the future. 52, 53 Exogenous RNAi molecules (siRNA, oligodeoxynucleotides, micro-RNA, and short-hairpin RNA) also have the potential for therapeutic agents in human diseases, 53 and several factors that confer resistance to cancer cells are over-expressed in a broad range of tumors. Thus, combining the selective knockdown of these factors using RNAi tools with chemotherapeutic drugs could be an effective strategy for anti-cancer treatment. 54 Because the aB-crystallin expressed in glioma cells plays a pivotal anti-apoptotic role, the combined therapy of aB-crystallin siRNA with SAHA could be a therapeutic strategy to control aB-crystallin-expressing glioma cells.
In summary, aB-crystallin is expressed in glioma cells and overrides the anti-apoptotic activity of XIAP. 
